Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Juanola Falgarona, Martí ^a,b,c   Salas Salvadó, Jordi ^a,b,c   Estruch, Ramon ^b,c,d   Portillo, Maria P ^c,e   Casas, Rosa ^b,c,d   Miranda, Jonatan ^c,e   Martínez González, Miguel A ^c,f   Bulló, Mònica ^a,b,c  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^f UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Diabetes; Inflammation; Insulin resistance; Vitamin K

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OLIVE OIL; PHYTOMENADIONE; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; VITAMIN INTAKE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIET, MEDITERRANEAN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN K 1;

EID: 84871967263     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-7     Document Type: Article

References (36)

1. Iwamoto J, Sato Y, Takeda T, Matsumoto H. Bone quality and vitamin K2 in type 2 diabetes: review of preclinical and clinical studies. Nutr Rev 2011, 69(3):162-167. 10.1111/j.1753-4887.2011.00380.x, 21348880.
2. Shearer MJ. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc 1997, 56(3):915-937. 10.1079/PNS19970099, 9483660.
3. Booth SL. Roles for vitamin K beyond coagulation. Annu Rev Nutr 2009, 29:89-110. 10.1146/annurev-nutr-080508-141217, 19400704.
4. Yoshida M, Booth SL, Meigs JB, Saltzman E, Jacques PF. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr 2008, 88(1):210-215.
5. Kumar R, Binkley N, Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr 2010, 92(6):1528-1532. 10.3945/ajcn.2010.30108, 2980972, 20881072.
6. Beulens JW, van Der ADL, Grobbee DE, Sluijs I, Spijkerman AM, Van Der Schouw YT. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 2010, 33(8):1699-1705. 10.2337/dc09-2302, 2909045, 20424220.
7. Ibarrola-Jurado N, Salas-Salvado J, Martinez-Gonzalez MA, Bullo M. Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease. Am J Clin Nutr 2012, 96(5):1113-1118. 10.3945/ajcn.111.033498, 23034962.
8. Ohsaki Y, Shirakawa H, Hiwatashi K, Furukawa Y, Mizutani T, Komai M. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006, 70(4):926-932. 10.1271/bbb.70.926, 16636460.
9. Shea MK, Booth SL, Massaro JM, Jacques PF, D'Agostino RBS, Dawson-Hughes B, Ordovas JM, O'Donnell CJ, Kathiresan S, Keaney JF, Vasan RS, Benjamin EJ. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008, 167(3):313-320. 3151653, 18006902.
10. Shea MK, Dallal GE, Dawson-Hughes B, Ordovas JM, O'Donnell CJ, Gundberg CM, Peterson JW, Booth SL. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 2008, 88(2):356-363. 2532855, 18689371.
11. Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, Fiol M, Gomez-Gracia E, Lopez-Sabater MC, Vinyoles E, Aros F, Conde M, Lahoz C, Lapetra J, Saez G, Ros E, PREDIMED Study Investigators Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145(1):1-11. PREDIMED Study Investigators.
12. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ros E, Covas MI, Fiol M, Warnberg J, Aros F, Ruiz-Gutierrez V, Lamuela-Raventos RM, Lapetra J, Munoz MA, Martinez JA, Saez G, Serra-Majem L, Pinto X, Mitjavila MT, Tur JA, Portillo MD, Estruch R, for the PREDIMED Study Investigators Cohort profile: design and methods of the PREDIMED study. Int J Epidemiol 2012, 41(2):377-385. 10.1093/ije/dyq250, 21172932, for the PREDIMED Study Investigators.
13. Fernandez-Ballart JD, Pinol JL, Zazpe I, Corella D, Carrasco P, Toledo E, Perez-Bauer M, Martinez-Gonzalez MA, Salas-Salvado J, Martin-Moreno JM. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 2010, 103(12):1808-1816. 10.1017/S0007114509993837, 20102675.
14. Schroder H, Fito M, Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Lamuela-Raventos R, Ros E, Salaverria I, Fiol M, Lapetra J, Vinyoles E, Gomez-Gracia E, Lahoz C, Serra-Majem L, Pinto X, Ruiz-Gutierrez V, Covas MI. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr 2011, 141(6):1140-1145. 10.3945/jn.110.135566, 21508208.
15. Moreiras O, Carbajal A, Cabrera L, Cuadrado C. Tablas de composición de los alimentos. (Food Composition Tables) 2005, Madrid: Pirámide, 9th.
16. Mataix Verdú J. Tabla de composicion de alimentos [Food Composition Tables] 2003, Granada (Spain): Universidad de Granada, 4th.
17. Pan Y, Jackson RT. Dietary phylloquinone intakes and metabolic syndrome in US young adults. J Am Coll Nutr 2009, 28(4):369-379.
18. Bullo M, Moreno-Navarrete JM, Fernandez-Real JM, Salas-Salvado J. Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and beta cell function in elderly men at high cardiovascular risk. Am J Clin Nutr 2012, 95(1):249-255. 10.3945/ajcn.111.016642, 22170359.
19. Fernandez-Fernandez L, Bellido-Martin L, Garcia de Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost 2008, 100(4):604-610.
20. Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res 2007, 13(7):2236-2245. 10.1158/1078-0432.CCR-06-2308, 17404108.
21. Tanaka S, Nishiumi S, Nishida M, Mizushina Y, Kobayashi K, Masuda A, Fujita T, Morita Y, Mizuno S, Kutsumi H, Azuma T, Yoshida M. Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-kappaB activation. Clin Exp Immunol 2010, 160(2):283-292. 2857952, 20030669.
22. Ohsaki Y, Shirakawa H, Miura A, Giriwono PE, Sato S, Ohashi A, Iribe M, Goto T, Komai M. Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor kappaB through the repression of IKKalpha/beta phosphorylation. J Nutr Biochem 2010, 21(11):1120-1126. 10.1016/j.jnutbio.2009.09.011, 20149620.
23. Li J, Lin JC, Wang H, Peterson JW, Furie BC, Furie B, Booth SL, Volpe JJ, Rosenberg PA. Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci 2003, 23(13):5816-5826.
24. Reddi K, Henderson B, Meghji S, Wilson M, Poole S, Hopper C, Harris M, Hodges SJ. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995, 7(3):287-290. 10.1006/cyto.1995.0034, 7640347.
25. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006, 116(7):1793-1801. 10.1172/JCI29069, 1483173, 16823477.
26. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009, 94(9):3171-3182. 10.1210/jc.2008-2534, 19509100.
27. Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH, Jang HO, Yun I, Kim KW, Kwon YG, Yoo MA, Bae MK. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 2008, 1783(5):886-895. 10.1016/j.bbamcr.2008.01.004, 18241674.
28. Lee WJ, Wu CS, Lin H, Lee IT, Wu CM, Tseng JJ, Chou MM, Sheu WH. Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway. Int J Obes (Lond) 2009, 33(4):465-472.
29. Tong J, Prigeon RL, Davis HW, Bidlingmaier M, Kahn SE, Cummings DE, Tschop MH, D'Alessio D. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 2010, 59(9):2145-2151. 10.2337/db10-0504, 2927935, 20584998.
30. Schofl C, Horn R, Schill T, Schlosser HW, Muller MJ, Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87(10):4607-4610. 10.1210/jc.2002-020505, 12364442.
31. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003, 52(10):2546-2553. 10.2337/diabetes.52.10.2546, 14514639.
32. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004, 89(4):1630-1635. 10.1210/jc.2003-031572, 15070922.
33. Ostergard T, Hansen TK, Nyholm B, Gravholt CH, Djurhuus CB, Hosoda H, Kangawa K, Schmitz O. Circulating ghrelin concentrations are reduced in healthy offspring of Type 2 diabetic subjects, and are increased in women independent of a family history of Type 2 diabetes. Diabetologia 2003, 46(1):134-136.
34. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, Eppler E, Bouzakri K, Wueest S, Muller YD, Hansen AM, Reinecke M, Konrad D, Gassmann M, Reimann F, Halban PA, Gromada J, Drucker DJ, Gribble FM, Ehses JA, Donath MY. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 2011, 17(11):1481-1489. 10.1038/nm.2513, 22037645.
35. Nie Y, Ma RC, Chan JC, Xu H, Xu G. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes. FASEB J 2012, 26(6):2383-2393. 10.1096/fj.11-196782, 22366643.
36. Omar B, Banke E, Guiguis E, Kesson L, Manganiello V, Lyssenko V, Groop L, Gomez MF, Degerman E. Regulation of the pro-inflammatory cytokine osteopontin by GIP in adipocytes - A role for the transcription factor NFAT and phosphodiesterase 3B. Biochem Biophys Res Commun 2012, 425(4):812-819. 10.1016/j.bbrc.2012.07.157, 22892131.